Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Rangering i aksjer #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Aksjekurs
$19.63
Markedsverdi
$47.10B
Endring (1 dag)
1.80%
Endring (1 år)
-7.33%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategori

Inntekter for Sun Pharmaceutical Industries Limited (SUNPHARMA)
Inntekter i Dec 2025 TTM: $6.31B
Ifølge de nyeste økonomiske rapportene til Sun Pharmaceutical Industries Limited er selskapets nåværende inntekter (TTM) $6.31B. I 2024 hadde selskapet inntekter på $5.82B en økning sammenlignet med inntektene i 2023, som var $5.34B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Sun Pharmaceutical Industries Limited fra 2004 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $6.31B 2.69%
2025 $6.15B 5.70%
2024 $5.82B 8.91%
2023 $5.34B 4.87%
2022 $5.09B 11.28%
2021 $4.58B 4.98%
2020 $4.36B 4.14%
2019 $4.19B 3.17%
2018 $4.06B -15.97%
2017 $4.83B 13.79%
2016 $4.24B -3.35%
2015 $4.39B 63.63%
2014 $2.68B 29.00%
2013 $2.08B 31.80%
2012 $1.58B 22.91%
2011 $1.28B 47.70%
2010 $869.23M 3.29%
2009 $841.54M 0.33%
2008 $838.79M 70.54%
2007 $491.84M 33.83%
2006 $367.50M 33.92%
2005 $274.42M 20.98%
2004 $226.82M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$4.43B -29.76%
FR
$24.76B 292.14%
DE
$28.60B 352.97%
JP
$9.47B 49.96%
US
$25.92B 310.58%
GB